Wagner M. Zago
Chief Tech/Sci/R&D Officer en PROTHENA CORPORATION PLC .
Perfil
Wagner M.
Zago is currently the Chief Scientific Officer at Prothena Corp.
Plc since 2017.
Prior to this, he worked as a Scientist at Elan Pharmaceuticals LLC from 2006 to 2012.
Dr. Zago completed his graduate and doctorate degrees at the University of Sao Paulo and his undergraduate degree at Universidade Federal De Sao Paulo.
Cargos activos de Wagner M. Zago
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTHENA CORPORATION PLC | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Antiguos cargos conocidos de Wagner M. Zago.
| Empresas | Cargo | Fin |
|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 02/01/2012 |
Formación de Wagner M. Zago.
| University of Sao Paulo | Doctorate Degree |
| Universidade Federal De Sao Paulo | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Wagner M. Zago
